2025 HCPCS Code C7533
Percutaneous transluminal coronary angioplasty, single major coronary artery or branch with transcatheter placement of radiation delivery device for subsequent coronary intravascular brachytherapy
TAGS: device major radiation artery subsequent delivery intravascular coronary transluminal transcatheter brachytherapy placement branch percutaneous singleShort Description | Ptca w/ plcmt brachytx dev |
Product Note | 0229 |
HCPCS Action Code | N - No maintenance for this code |
HCPCS Coverage Code | C - Carrier judgment |
HCPCS Code Added Date | January 01, 2023 |
HCPCS Action Effective Date | January 01, 2023 |
HCPCS Pricing Indicator Code | 11 - Price established using national rvu's |
HCPCS Type Of Service Code | 2 - Surgery |
HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
HCPCS Anesthesia Base Unit Quantity | 0 |
HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- C9035 - Injection, aristada initio
- C9036 - Injection, patisiran
- C9037 - Injection, risperidone
- C9038 - Inj mogamulizumab-kpkc
- C9039 - Injection, plazomicin
- C9040 - Injection, fremanezumab-vfrm
- C9041 - Inj, coagulation factor xa
- C9042 - Inj., belrapzo 1 mg
- C9043 - Injection, levoleucovorin
- C9044 - Injection, cemiplimab-rwlc
- C9045 - Moxetumomab pasudotox-tdfk
- C9046 - Cocaine hcl nasal (goprelto)
- C9047 - Injection, caplacizumab-yhdp
- C9048 - Dexamethasone ophth insert
- C9049 - Injection, tagraxofusp-erzs
- C9050 - Injection, emapalumab-lzsg
- C9051 - Injection, omadacycline
- C9052 - Injection, ravulizumab-cwv
- C9053 - Inj, crizanlizumab-tmca
- C9054 - Injection, lefamulin